Gastrointestinal Effects of Antidepressants

Comparison of Sertraline and Escitalopram

The American Academy of Family Physicians recommends starting with low doses of sertralina, 25-50 mg/día, to reduce the incidence of gastrointestinal side effects 1
The American Academy of Family Physicians suggests that escitalopram may be better tolerated than sertraline, with a lower risk of gastrointestinal side effects 2
The American Academy of Child and Adolescent Psychiatry notes that escitalopram and citalopram may have fewer effects on CYP450 isoenzymes, contributing to a lower profile of drug interactions and side effects 3, 4
The Annals of Internal Medicine reports that gastrointestinal side effects are the most common adverse effects of selective serotonin reuptake inhibitors (SSRIs) and the primary cause of treatment discontinuation 5
The Journal of the American Academy of Child and Adolescent Psychiatry recommends monitoring gastrointestinal symptoms, especially during the first 1-2 weeks of treatment 4
The American family physician suggests that taking medication with food may help reduce some gastrointestinal side effects, especially nausea 2
The Clinical Gastroenterology and Hepatology notes that in patients with gut-brain interaction disorders (such as irritable bowel syndrome), the gastrointestinal effects of SSRIs may be more pronounced and should be carefully considered 6

Heartburn is explicitly listed among the common adverse effects of SSRIs as a class, including sertraline, that typically emerge within the first few weeks of treatment 7, 8
Heartburn is a recognized common side effect of sertraline and other SSRIs, typically emerging within the first few weeks of treatment 7, 8

SSRIs have been associated with an increased risk of upper gastrointestinal bleeding, though this is a separate and less common concern 9, 10

Sertraline has been specifically associated with discontinuation syndrome, which can include diarrhea as a sequela, particularly in patients receiving 50-150 mg daily, where diarrhea is one of the most frequently reported adverse effects 11
The American Academy of Child and Adolescent Psychiatry recommends monitoring for signs of serotonin syndrome, especially if the patient is on multiple serotonergic medications, as serotonin syndrome can arise within 24-48 hours after combining serotonergic medications or dose increases, and can include gastrointestinal symptoms such as nausea, vomiting, and diarrhea 11

If diarrhea appears as part of a constellation of symptoms including mental status changes, autonomic instability, and neuromuscular symptoms, serotonin syndrome must be ruled out, as serotonin syndrome can include gastrointestinal symptoms such as nausea, vomiting, and diarrhea 11

Mental status changes, such as agitation or confusion, can be indicative of serotonin syndrome, especially in patients on multiple serotonergic medications or with recent dose increases, according to the American Academy of Child and Adolescent Psychiatry 12
Autonomic instability, including tachycardia, labile blood pressure, and hyperthermia, are also symptoms of serotonin syndrome that require immediate attention, as noted by the American Academy of Child and Adolescent Psychiatry 12
Neuromuscular symptoms like tremor, rigidity, myoclonus, and hyperreflexia can occur in serotonin syndrome, highlighting the need for careful monitoring, as recommended by the American Academy of Child and Adolescent Psychiatry 12

The American Academy of Child and Adolescent Psychiatry suggests that sertraline is associated with discontinuation syndrome, which can include dizziness, fatigue, headaches, nausea, vomiting, diarrhea, insomnia, anxiety, and irritability, emphasizing the need for careful monitoring during the switch to escitalopram 12
A brief taper of sertraline rather than abrupt cessation can help minimize withdrawal symptoms, as advised by the American Academy of Child and Adolescent Psychiatry 12
Higher doses or blood concentrations of sertraline are associated with more adverse effects, not fewer, according to the American Academy of Child and Adolescent Psychiatry 12

Selective serotonin reuptake inhibitors (SSRIs) cause fewer constipation‑type gastrointestinal adverse events than tricyclic antidepressants, which are associated with a higher incidence of constipation. (Evidence from a 2000 comparative study) 13

Gastro‑intestinal symptoms are the most frequent adverse events leading to discontinuation of SSRI therapy; they represent the primary reason patients stop these medications. (Observational data from a 2022 gastroenterology cohort) 14

The 2022 American Gastroenterological Association (AGA) guidelines advise against prescribing SSRIs for IBS because of insufficient efficacy and the potential to aggravate bowel symptoms. (Guideline recommendation) 15
The same AGA guidance highlights that SSRIs may worsen diarrhea‑predominant IBS by increasing gastric and intestinal motility. (Guideline recommendation) 16

SSRIs increase gastric and intestinal motility, which can exacerbate conditions characterized by diarrhea‑predominant bowel patterns. (Mechanistic evidence reported in 2022 gastroenterology literature) 16

All facts are presented with generic patient descriptors and reflect the strength of evidence where indicated (e.g., guideline recommendations).